Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.77 Billion
CN¥20.33 Billion CNY
Market Cap Rank
#4946 Global
#577 in China
Share Price
CN¥21.03
Change (1 day)
-0.80%
52-Week Range
CN¥16.79 - CN¥29.50
All Time High
CN¥29.50
About

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides… Read more

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.003x

Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a cash flow conversion efficiency ratio of -0.003x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.23 Million) by net assets (CN¥2.30 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.26 Billion CN¥162.75 Million 0.072x +48.32%
2023-12-31 CN¥2.32 Billion CN¥112.78 Million 0.049x -41.85%
2022-12-31 CN¥2.37 Billion CN¥198.16 Million 0.084x +41.49%
2021-12-31 CN¥2.34 Billion CN¥138.33 Million 0.059x +68.91%
2020-12-31 CN¥2.31 Billion CN¥80.71 Million 0.035x +24.67%
2019-12-31 CN¥2.67 Billion CN¥74.86 Million 0.028x -21.91%
2018-12-31 CN¥4.75 Billion CN¥170.72 Million 0.036x +501.06%
2017-12-31 CN¥4.42 Billion CN¥26.43 Million 0.006x -72.53%
2016-12-31 CN¥4.16 Billion CN¥90.63 Million 0.022x +130.40%
2015-12-31 CN¥2.25 Billion CN¥-160.95 Million -0.072x -237.69%
2014-12-31 CN¥659.50 Million CN¥34.32 Million 0.052x -68.91%
2013-12-31 CN¥615.08 Million CN¥102.96 Million 0.167x +1697.12%
2012-12-31 CN¥619.60 Million CN¥-6.49 Million -0.010x +19.78%
2011-12-31 CN¥607.13 Million CN¥-7.93 Million -0.013x -126.80%
2010-12-31 CN¥595.89 Million CN¥29.05 Million 0.049x -64.39%
2009-12-31 CN¥583.87 Million CN¥79.94 Million 0.137x +639.34%
2008-12-31 CN¥554.08 Million CN¥10.26 Million 0.019x -0.09%
2007-12-31 CN¥536.90 Million CN¥9.95 Million 0.019x +152.86%
2006-12-31 CN¥513.86 Million CN¥-18.02 Million -0.035x -104.44%
2005-12-31 CN¥45.26 Million CN¥35.74 Million 0.790x +51.26%
2004-12-31 CN¥36.64 Million CN¥19.12 Million 0.522x +68.00%
2003-12-31 CN¥296.07 Million CN¥91.99 Million 0.311x +109.74%
2002-12-31 CN¥490.79 Million CN¥72.70 Million 0.148x +109.51%
2001-12-31 CN¥475.05 Million CN¥-740.34 Million -1.558x -955.58%
2000-12-31 CN¥1.08 Billion CN¥196.15 Million 0.182x +336.55%
1999-12-31 CN¥1.05 Billion CN¥-80.62 Million -0.077x +15.64%
1998-12-31 CN¥689.39 Million CN¥-62.93 Million -0.091x --